KoBioLabs

KoBioLabs Graham Number

The Graham Number of KoBioLabs (348150.KQ) as of Nov 16, 2026 is 8,116.64 KRW. In the previous year, Graham Number was 3,469.91 KRW — a change of 133.91% (higher).

Graham Number

8,116.64KRW

YoY

133.91%

Last updated:

Graham Number of KoBioLabs is 2025 8,116.64 KRW. Graham Number of KoBioLabs was 2024 3,469.91 KRW. It decreases by 133.91% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

Graham Number of KoBioLabs is 8,116.64 KRW in 2025.

On Eulerpool you can find the complete historical development of Graham Number KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — KoBioLabs

All Key Metrics — KoBioLabs